Over 37 Lakh Dog Bite Cases In 2024: Centre Steps Up Stray Dog Control Measures
Municipalities, under Article 243(W), are mandated to implement the Animal Birth Control (ABC) Programme, focusing on neutering and anti-rabies vaccination of stray dogs. To streamline this, the government notified the Animal Birth Control Rules, 2023, superseding the earlier 2001 rules.
These new rules incorporate Supreme Court and Delhi High Court directives, including guidelines for feeding and care of community animals. The Animal Welfare Board of India (AWBI) has issued multiple advisories to ensure effective street dog population control and promote man-dog conflict resolution.
Between 2024 and June 2025, 166 letters were sent to RWAs and local bodies to ensure compliance.
On the health front, the Ministry of Health is implementing the National Rabies Control Programme (NRCP), which includes setting up Model Anti-Rabies Clinics, ensuring vaccine availability, and launching the "Rabies-Free City" initiative.
Additionally, the Centre has allocated Rs 3,535.86 lakh over the past five years for anti-rabies vaccine procurement under the ASCAD scheme, including Rs 1,423.41 lakh in 2024-25 for over 80 lakh doses. The government has also urged States/UTs to adopt the ABC Programme through local bodies to enhance public safety, particularly for children.
The Department of Animal Husbandry conducts a five-year livestock census, which includes stray dogs, while municipalities have been advised to conduct annual local censuses under the ABC Rules.
The Centre's comprehensive approach aims to address both public health and animal welfare in tackling the growing stray dog issue.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
12 minutes ago
- News18
Chhattisgarh CM Vishnu Deo Sai Invites PM Modi To Attend 'Amrit Rajat Mahotsav' In Raipur
Chhattisgarh CM Vishnu Deo Sai met PM Modi in New Delhi to discuss state's development. He invited PM Modi to the state's 25th anniversary celebrations on November 1. Chhattisgarh Chief Minister Vishnu Deo Sai on Friday met Prime Minister Narendra Modi in New Delhi. During the courtesy meet, Chhattisgarh's development works and future priorities were discussed. CM Vishnu Deo Sai also invited PM Modi to the celebration of state's 25th anniversary. To mark 25 years since Chhattisgarh was formed, 'Amrit Rajat Mahotsav' will be held in Raipur on November 1. CM Sai shared the pictures of his meeting with PM at the Parliament House and wrote, 'Today, I had a courtesy meeting with the esteemed Prime Minister Shri Narendra Modi ji at the Parliament House, where I apprised him of Chhattisgarh's development works, public welfare schemes, and future priorities." 'On the occasion of the 25th anniversary of the state's formation, I invited the Honorable Prime Minister ji on behalf of the three crore people of Chhattisgarh to the 'Amrit Rajat Mahotsav' to be held in Raipur on November 1. I am confident that his esteemed presence will lend the highest dignity to this historic event," he added. Furthermore, Chhattisgarh CM also discussed initiatives to bring positive changes in the tribal and Naxal affected regions. On Thursday, Chhattisgarh CM met Union Minister of Labour & Employment, Youth Affairs and Sports Mansukh Mandaviya in New Delhi. He discussed key steps to boost sports and healthcare education in Chhattisgarh. As per the PTI report, CM Sai proposed the establishment of 220-bed medical and nursing colleges in Raipur and Bilaspur, aimed at increasing the quality of health education and expanding access to better medical facilities across the state. In response, Union Minister Mandaviya assured that the central government would soon take a positive decision and initiate the process for granting approval. view comments First Published: August 01, 2025, 15:09 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
19 minutes ago
- Time of India
70% enrolment of participants for Phase III clinical trial of dengue vaccine completed: Centre
Seventy percent enrolment of participants for the Phase III clinical trial of the indigenous one-shot dengue vaccine , DengiAll , has been completed, Minister of State for Health, Prataprao Jadhav, told Lok Sabha on Friday. The Indian Council of Medical Research ( ICMR ) has undertaken a clinical trial titled phase III, multicentre, randomised, double-blind, placebo controlled study to evaluate the efficacy, immunogenicity and safety of the single-dose Dengue Tetravalent vaccine, live attenuated (Recombinant, Lyophilised) - 'DengiAll', Jadhav said in a written reply. Explore courses from Top Institutes in Please select course: Select a Course Category Cybersecurity Project Management MCA Finance MBA PGDM Technology Healthcare Data Science Data Analytics CXO Design Thinking Data Science Leadership others healthcare Degree Others Digital Marketing Management Artificial Intelligence Product Management Public Policy Operations Management Skills you'll gain: Duration: 10 Months MIT xPRO CERT-MIT xPRO PGC in Cybersecurity Starts on undefined Get Details "The trial involves over 10,000 participants, out of which more than 70 per cent enrolment has been completed. The trial has been implemented in 20 sites across India," he said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like War Thunder - Register now for free and play against over 75 Million real Players War Thunder Play Now Undo The sites are JSS Medical College and Hospital, Mysuru (Karnataka), Bangalore Medical College and Research Institute, and All India Institute of Medical Sciences, Bibinagar (Telangana). The approximate budget for the trial is Rs 1.3 to 1.5 crore per site, Jadhav said. Live Events According to ICMR, there is no specific antiviral treatment or licensed vaccines for dengue and the treatment is supportive in nature, Jadhav said. A total of 5,73,563 laboratory confirmed dengue cases were reported through the Integrated Health Information Platform (IHIP) in 2024, according to information shared by the National Centre for Disease Control (NCDC) , . According to ICMR, all four serotypes of the dengue virus (DENV-1, DENV-2, DENV-3, and DENV -4) are known to circulate and co-circulate in India. Multiple serotypes can be present in the same geographical region and can even infect the same individual at the same time. Hence, participants have been enrolled in the ICMR vaccine trial from different zones where these four serotypes circulate in order to test the efficacy of the vaccine against all four serotypes, Jadhav said. The minister also said that the Union Health Ministry, Director General of Health Services, and National Centre for Vector Borne Disease Control (NCVBDC) regularly monitor the situation of dengue outbreaks across the country for assessing the disease situation, preparedness, technical guidance and to sensitise and forewarn the states. Under the National Health Mission, adequate budgetary support is provided to states and Union territories for dengue control activities such as epidemic preparedness, monitoring, case management, vector control (provision of domestic breeding checkers, ASHA involvement, insecticide, fogging machines), training, intersectoral convergence, awareness activities, etc. For surveillance and free of cost diagnosis of dengue, Sentinel Surveillance Hospitals with laboratory facility and Apex Referral laboratories with advance diagnostic facilities have been identified across the country, Jadhav said. The government of India has developed national guidelines on dengue treatment/management, in consultation with experts, which have been shared with all the states and UTs for implementation. The guidelines emphasise the preparedness of hospitals for case treatment/management. In addition, advisories have been issued from time to time to states/UTs for prevention and control of dengue, including case management, the minister said.
Time of India
29 minutes ago
- Time of India
MGM SevenHills hospital launches advanced Liver Transplant Institute in Visakhapatnam
VISAKHAPATNAM: MGM SevenHills Hospital has launched a state-of-the-art Liver Transplant Institute, bringing world-class liver care to the region under the leadership of Dr Thiagarajan Srinivasan, Senior Consultant and Director, Institute of Liver Diseases, Transplant & HPB Surgery. Dr Thiagarajan is an internationally acclaimed liver transplant and HPB (Hepato-Pancreato-Biliary) surgeon with 15 years of experience. A graduate of Thanjavur Medical College and PGI Chandigarh, he has performed over 1,700 liver transplants and has a cumulative experience of more than 3,500 transplants, including living donor, deceased donor, and paediatric procedures. He has also carried out more than 1,000 advanced HPB surgeries, both open and laparoscopic. The new institute focuses on using advanced technology and medical protocols to treat a wide range of liver, pancreatic, and biliary conditions. It offers comprehensive care, including preventive, medical, interventional, and surgical treatments, along with living and deceased donor liver transplants. With the launch of this facility, patients in Visakhapatnam and across Andhra Pradesh no longer need to travel to Chennai, Hyderabad, or Bangalore for advanced liver treatments. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Why Seniors Are Snapping Up This TV Box, We Explain! Techno Mag Learn More Undo MGM SevenHills now provides complete liver care and transplantation services locally, meeting global standards. Dr Thiagarajan stressed the importance of increasing awareness about liver transplantation and related surgeries, stating that thousands of lives could be saved each year from conditions such as liver cirrhosis, liver cancer, acute liver failure, colorectal liver metastasis, gallbladder cancer, and bile duct cancer. He added that more people in Andhra Pradesh can now access financial support under the Chief Minister's Relief Fund, which provides up to Rs 10 lakh per transplant. Dr Viswanath R., Head of Interventional Gastroenterology and Liver Diseases at the hospital, said the new institute, equipped with world-class infrastructure and expertise, would enhance diagnosis and treatment of gastroenterology and liver disorders, offering comprehensive care for all digestive system-related diseases.
